Martin H Steinberg, Bernard G Forget, Douglas R Higgs, David J Weatherall

Disorders of Hemoglobin

Genetics, Pathophysiology, and Clinical Management

• Gebundenes Buch

Produktbeschreibung

Completely revised new edition of the definitive reference on disorders of hemoglobin.

Produktdetails

• Verlag: Cambridge University Press
• 2nd Revised edition
• Seitenzahl: 846
• Erscheinungstermin: 17. August 2009
• Englisch
• Abmessung: 287mm x 219mm x 45mm
• Gewicht: 2945g
• ISBN-13: 9780521875196
• ISBN-10: 0521875196
• Artikelnr.: 27272986

Autorenporträt

Martin H. Steinberg is Professor of Medicine, Pediatrics, Pathology and Laboratory Medicine at Boston University School of Medicine. He is also Director at the Center of Excellence in Sickle Cell Disease, Boston Medical Center.

Inhaltsangabe

Foreword H. Franklin Bunn; Preface; Introduction David Weatherall; Part I.
The Cellular, Molecular and Genetic Basis of Hemoglobin Disorders:
Introduction; 1. The development of hematopoiesis Elaine Dzierzak; 2.
Erythropoiesis S. Philipsen and W. G. Wood; 3. The normal structure
regulation of human globin gene clusters Bernard G. Forget and Ross C.
Hardison; 4. The normal regulation of globin gene expression Gerd A. Blobel
and Mitchell J. Weiss; 5. The molecular and cellular basis of developmental
globin gene switching George Stamatoyannopoulos; 6. Structure and function
of hemoglobin and its dysfunction in sickle cell disease Daniel
Kim-Shapiro; 7. Hemoglobins of the embryo, fetus and adult Martin H.
Steinberg and Ronald L. Nagel; Part II. Pathophysiology of Hemoglobin and
its Disorders: Introduction; 8. Vascular biology Dhananjat Kaul; 9. The
erythrocyte membrane Clint Joiner and Patrick Gallagher; 10. The biology of
vascular nitric oxide Jane A. Leopold and Joseph Loscalzo; 11. Mechanisms
and complications of hemolysis in sickle cell disease and thalassemia
Gregory J. Kato and Mark T. Gladwin; 12. The importance of animal models in
understanding pathophysiology Mary Fabry; Part III. ¿ Thalassemia:
Introduction: 13. The molecular basis of alpha thalassemia Douglas R. Higgs
and Vip Viprakasit; 14. The pathophysiology and clinical features of alpha
thalassemia Douglas R. Higgs, Vip Viprakasit and Don Bowden; 15. Alpha
thalassemia with mental retardation and myelodysplasia Douglas R. Higgs,
Richard Gibbons, and David Steensma; Part IV. Beta Thalassemia:
Introduction: 16. The molecular basis of beta thalassemia S. L. Thein and
W. G. Wood; 17. Clinical aspects of beta thalassemia and related disorders
Nancy F. Olivieri, D. K. Bowden, and D. J. Weatherall; 18. HbE disorders
Suthat Fuchareon and David Weatherall; Part V. Sickle Cell Disease:
Introduction: 19. Clinical and pathophysiological aspects of sickle cell
anemia Martin Steinberg, Kwaku Ohene-Frempong, and Matthew M. Heeney; 20.
Biology of pain and treatment of the sickle cell painful episode Samir K.
Ballas and James R. Eckman; 21. HbSC disease and HbC Martin H. Steinberg
and Ronald L. Nagel; 22. Sickle cell trait Martin H. Steinberg; 23. Other
sickle hemoglobinopathies Martin H. Steinberg; Part VI. Other Clinically
Important Disorders of Hemoglobin: Introduction: 24. Unstable hemoglobins;
hemoglobins with altered oxygen affinity; hemoglobin M; other variants of
clinical and biological interest Martin H. Steinberg and Ronald L. Nagel;
25. Dyshemoglobinemias Neeraj Agarwal and Ronald L. Nagel; Part VII.
Special Topics in Hemoglobinopathies: Introduction: 26. Population genetics
and global health burden David J. Weatherall and Thomas N. Williams; 27.
Genetic modulation of sickle cell disease and thalassemia Martin H.
Steinberg and Ronald L. Nagel; 28. Developments in laboratory methods to
detect hemoglobinopathies Mary Fabry and John M. Old; Part VIII. New
Approaches to the Treatment of Hemoglobinopathies and Thalassemia:
Introduction: 29. Transfusion and iron chelation John Porter, Alan R. Cohen
and Janet L. Kwiatkowski; 30. Induction of HbF Yogen Saunthararajah and
George F. Atweh; 31. Novel approaches to treatment - (anitoxidants,
statins, anti-inflammatory agents, K-Cl and Gardos inhibitors, other
transport inhibitors, NO) Carlo Brugnara, Kirkwood A. Pritchard, Jr and
Cheryl Hillery; 32. Stem cell transplantation Emanuele Angelucci and Mark
Walters; 33. Gene therapy Derek A. Persons, Brian P. Sorrentino, and Arthur
W. Nienhuis.